Head-To-Head Review: Joint (NASDAQ:JYNT) vs. Cigna Group (NYSE:CI)

Joint (NASDAQ:JYNT) and Cigna Group (NYSE:CI) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, profitability, analyst recommendations and earnings.

Analyst Recommendations

This is a summary of current recommendations and price targets for Joint and Cigna Group, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Joint	0	0	2	0	3.00
Cigna Group	0	2	16	2	3.00

Joint currently has a consensus price target of $15.50, suggesting a potential upside of 35.73%. Cigna Group has a consensus price target of $380.39, suggesting a potential upside of 16.44%. Given Joint’s higher probable upside, research analysts clearly believe Joint is more favorable than Cigna Group.

Risk and Volatility

Joint has a beta of 1.48, meaning that its share price is 48% more volatile than the S&P 500. Comparatively, Cigna Group has a beta of 0.44, meaning that its share price is 56% less volatile than the S&P 500.

Valuation and Earnings

This table compares Joint and Cigna Group”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Joint	$51.90 million	3.37	-$8.53 million	($0.58)	-19.69
Cigna Group	$247.12 billion	0.35	$3.43 billion	$18.06	18.09

Cigna Group has higher revenue and earnings than Joint. Joint is trading at a lower price-to-earnings ratio than Cigna Group, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

76.9% of Joint shares are held by institutional investors. Comparatively, 87.0% of Cigna Group shares are held by institutional investors. 27.9% of Joint shares are held by insiders. Comparatively, 0.7% of Cigna Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Joint and Cigna Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Joint	-9.86%	1.60%	0.41%
Cigna Group	1.97%	18.63%	4.97%

Summary

Cigna Group beats Joint on 10 of the 14 factors compared between the two stocks.

About Joint

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.